, Tracking Stock Market Picks
Enter Symbol:
Myriad Genetics, Inc. (MYGN) [hlAlert]

up 29.32 %

Myriad Genetics, Inc. (MYGN) rated Outperform by William Blair

Posted on: Tuesday,  Aug 4, 2009  8:25 AM ET by William Blair

William Blair rated Outperform Myriad Genetics, Inc. (NASDAQ: MYGN) on 08/04/2009, when the stock price was $27.42. Since
then, Myriad Genetics, Inc. has gained 29.32% as of 01/21/2016's recent price of $35.46.
If you would have followed this William Blair's recommendation on MYGN, you would have gained 29.32% of your investment in 2361 days.

Myriad Genetics, Inc. uses gene-based medicine to develop therapeutic and molecular diagnostic products. They employ a variety of proprietary proteomic technologies to discover disease genes and to understand the role these genes and their related proteins play in the onset and progression of disease. They have integrated these technologies using bioinformatics and robotics systems to conduct their research efforts on a high-throughput basis. This has enabled them to identify numerous proteins as targets for new drugs and molecular diagnostic tests.

The Equity Research department provides the firm's clients with in-depth investment analysis and investment recommendations. Acting as the company's laboratory for new investment ideas, it specializes in providing investment analysis on quality growth companies. Located together in our Chicago office, our equity analysts currently follow a universe of nearly 360 companies.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/4/2009 8:25 AM Buy
as of 12/31/2009
1 Week down  -20.58 %
1 Month down  -9.90 %
3 Months down  -24.00 %
1 YTD down  -24.03 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy